510(k) K163504
K163504 is an FDA 510(k) premarket notification submitted by Viramed Biotech AG for the device "Borrelia B31 ViraChip IgG Test Kit". The FDA issued a decision of Substantially Equivalent on July 12, 2017. The device falls under product code LSR (Reagent, Borrelia Serological Reagent), a Class II device regulated under 21 CFR 866.3830. Viramed Biotech AG has at least 6 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 12, 2017
- Date Received
- December 14, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Reagent, Borrelia Serological Reagent
- Device Class
- Class II
- Regulation Number
- 866.3830
- Review Panel
- MI
- Submission Type